tradingkey.logo

iSpecimen Inc

ISPC
0.388USD
+0.007+1.89%
收盘 12/24, 13:00美东报价延迟15分钟
3.79M总市值
亏损市盈率 TTM

iSpecimen Inc

0.388
+0.007+1.89%

关于 iSpecimen Inc 公司

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

iSpecimen Inc简介

公司代码ISPC
公司名称iSpecimen Inc
上市日期Jun 17, 2021
CEOField (Katharyn)
员工数量24
证券类型Ordinary Share
年结日Jun 17
公司地址8 Cabot Road
城市WOBURN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编08101
电话17813016700
网址https://www.ispecimen.com/
公司代码ISPC
上市日期Jun 17, 2021
CEOField (Katharyn)

iSpecimen Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Specimens – contracts with customers
671.69K
94.19%
Shipping and other
41.44K
5.81%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Specimens – contracts with customers
671.69K
94.19%
Shipping and other
41.44K
5.81%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
其他
96.62%
持股股东
持股股东
占比
Renaissance Technologies LLC
1.57%
Virtu Americas LLC
0.65%
OBF Investments LLC
0.43%
Geode Capital Management, L.L.C.
0.43%
Scientech Research LLC
0.30%
其他
96.62%
股东类型
持股股东
占比
Hedge Fund
1.59%
Research Firm
0.86%
Investment Advisor
0.63%
Corporation
0.43%
Investment Advisor/Hedge Fund
0.43%
Individual Investor
0.26%
其他
95.80%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
26
96.86K
1.75%
-11.14K
2025Q2
31
133.51K
3.29%
-45.19K
2025Q1
37
201.48K
8.20%
-43.25K
2024Q4
37
175.36K
18.22%
-42.87K
2024Q3
38
178.54K
25.34%
-4.65K
2024Q2
37
155.60K
21.84%
-23.10K
2024Q1
38
168.39K
35.92%
-17.71K
2023Q4
42
174.70K
38.71%
-30.54K
2023Q3
48
208.00K
46.18%
-25.86K
2023Q2
48
208.72K
46.34%
-34.91K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Virtu Americas LLC
--
0%
-2.10K
-100.00%
Sep 30, 2024
OBF Investments LLC
42.10K
0.76%
+1.00
+0.00%
Dec 31, 2024
Geode Capital Management, L.L.C.
14.81K
0.27%
+4.08K
+37.96%
Jun 30, 2025
The Vanguard Group, Inc.
1.24K
0.02%
--
--
Aug 31, 2025
Wolf (James G)
25.25K
0.46%
-14.29K
-36.14%
Jun 03, 2024
BlackRock Institutional Trust Company, N.A.
2.83K
0.05%
--
--
Jun 30, 2025
Tower Research Capital LLC
6.19K
0.11%
+3.21K
+107.51%
Jun 30, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
公告日期
类型
比率
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1

常见问题

iSpecimen Inc的前五大股东是谁?

iSpecimen Inc 的前五大股东如下:
Virtu Americas LLC持有股份:0.00,占总股份比例:0.00%。
OBF Investments LLC持有股份:42.10K,占总股份比例:0.76%。
Geode Capital Management, L.L.C.持有股份:14.81K,占总股份比例:0.27%。
The Vanguard Group, Inc.持有股份:1.24K,占总股份比例:0.02%。
Wolf (James G)持有股份:25.25K,占总股份比例:0.46%。

iSpecimen Inc的前三大股东类型是什么?

iSpecimen Inc 的前三大股东类型分别是:
Renaissance Technologies LLC
Virtu Americas LLC
OBF Investments LLC

有多少机构持有iSpecimen Inc(ISPC)的股份?

截至2025Q3,共有26家机构持有iSpecimen Inc的股份,合计持有的股份价值约为96.86K,占公司总股份的1.75%。与2025Q2相比,机构持股有所增加,增幅为-1.54%。

哪个业务部门对iSpecimen Inc的收入贡献最大?

在FY2025Q2,Specimens – contracts with customers业务部门对iSpecimen Inc的收入贡献最大,创收671.69K,占总收入的94.19%。
KeyAI